Baring Private Equity Asia, Capital International and Bain Capital are in advanced talks to buy controlling stake in SRL Diagnostics, the country’s largest diagnostic chain and the listed subsidiary of Fortis Healthcare, according to a report in The Economic Times.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
